Every SEC Form 3/4/5 on record for this filer (CIK 1741284) — 4 issuers, 31 transactions. Section-16 filings only: what they filed, not a biography, and titles are as filed on their latest form at each issuer.
| Ticker | Company | Role as filed | On file | Forms | Open-market net |
|---|---|---|---|---|---|
| ZLAB | Zai Lab Ltd | Director | 2021-11-22 → 2026-06-22 | 9 | −$103,692 |
| ALKS | Alkermes plc. | Director | 2019-09-24 → 2026-05-22 | 18 | — |
| INFI | INFINITY PHARMACEUTICALS, INC. | Director · lapsed | 2020-03-17 → 2022-06-16 | 4 | — |
| NTGN | Neon Therapeutics, Inc. | President of R&D · lapsed | 2018-06-26 → 2020-05-06 | 8 | −$85,209 |
| Ticker | Date | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| ZLAB | 2026-03-17 | Buy | 1,731 | $18.91 | $32,733 | 56,630 |
| ZLAB | 2025-03-05 | Sell | 2,500 | $35.07 | $87,675 | 44,068 |
| ZLAB | 2024-09-03 | Sell | 2,500 | $19.50 | $48,750 | 46,568 |
2 of 4 issuers are covered and open a security page; the rest are on file here only.